Abstract
Hyperprolactinemia is a state of elevated levels of serum prolactin (PRL). The prevalence in the general population is not well known. Prolactin-secreting tumors have an annual incidence of 3/100,000 population. Normal PRL levels are about 15–30 μg/L in adults.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kars M, Souverein PC, Herings RM, Romijn JA, Vandenbroucke JP, de Boer A, et al. Estimated age- and sex-specific incidence and prevalence of dopamine agonist-treated hyperprolactinemia. J Clin Endocrinol Metab. 2009;94(8):2729–34.
Montgomery J, Winterbottom E, Jessani M, Kohegyi E, Fulmer J, Seamonds B, et al. Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment. J Clin Psychiatry. 2004;65(11):1491–8.
Coker F, Taylor D. Antidepressant-induced hyperprolactinaemia: incidence, mechanisms and management. CNS Drugs. 2010;24(7):563–74.
Yasui-Furukori N, Furukori H, Sugawara N, Fujii A, Kaneko S. Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia. J Clin Psychopharmacol. 2010;30(5):596–9.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Annamalai, A. (2017). Hyperprolactinemia. In: Medical Management of Psychotropic Side Effects. Springer, Cham. https://doi.org/10.1007/978-3-319-51026-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-51026-2_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-51024-8
Online ISBN: 978-3-319-51026-2
eBook Packages: MedicineMedicine (R0)